Market Place
Sourcing Support
Ajinomoto lay off 71 staffers in CA to CDMO business following $620M Forge buy
12 Aug 2024 //
FIERCE PHARMA
Ajinomoto To Lay Off 71 In CA After $620M Forge Biologics Acquisition
12 Aug 2024 //
FIERCE PHARMA
CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition
13 Nov 2023 //
FIERCE PHARMA
In filing, FDA lays out issues at Ajinomoto manufacturing site
19 Sep 2023 //
FIERCE PHARMA
Ajinomoto Bio-Pharma Services and Revance Announce Manufacturing Agreement
22 Dec 2020 //
PRNEWSWIRE
Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing
22 Dec 2020 //
PRNEWSWIRE
Aji Bio-Pharma, DNDi to develop treatment for cutaneous leishmaniasis infections
02 Oct 2020 //
BIOSPECTRUMASIA
Trio Pharmaceuticals & Ajinomoto Bio-Pharma Services Enter into a Development
30 Apr 2020 //
PRNEWSWIRE
HiFiBiO`s Kite-backed C round; Kyowa Kirin`s Parkinson`s nod; Relief for Sun
30 Aug 2019 //
FIERCE PHARMA
Ajinomoto Bio-Pharma Services takes control of GeneDesign
15 Apr 2019 //
FIERCE PHARMA
GeneDesign Joins Ajinomoto Bio-Pharma Services & Opens Oligonucleotide API Deve
08 Apr 2019 //
PR NEWSWIRE
Ajinomoto Appoints VP of Sales & Marketing
03 Apr 2019 //
CONTRACT PHARMA
Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth
12 Mar 2019 //
BIOSPACE
Ajinomoto and XL-protein unite to develop therapeutic compounds
20 Dec 2018 //
BIOSPECTRUM
Ajinomoto Introduces AJICAP Bioconjugation Technology for ADC Manufacturing
29 Nov 2018 //
BIOSPACE
Kyowa Kirin Bio doubles down on medical amino acids at Asian units
18 Aug 2017 //
ASIA NIKKEI
OmniChem launches flow chemistry for API commercial manufacturing
17 Apr 2017 //
PHARMABIZ
Merck KGaA spinoff licenses IBD drug to Eisai joint venture
01 Apr 2017 //
FIERCE BIOTECH
USFDA has Concerns about Granules - Ajinomoto OmniChem`s Vizag API Plant
21 Dec 2016 //
IN PHARMATECHNOLOGIST
A New Era Dawns at Louvain
16 Sep 2016 //
SPECIALITY CHEMICALS MAGAZINE
Eisai expands into Chinese generics market
28 Nov 2015 //
NIKKEI ASIAN REVIEW
Japan MHLW panel names 11 unapproved/off-label drugs for fast-track reviews
28 Apr 2015 //
FIERCE PHARMA ASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.